Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap

NCT02593149 is registered in ClinicalTrials.gov with Pursuit Vascular, Inc. as lead sponsor.

NCT NCT02593149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02593149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
Lead sponsor
Pursuit Vascular, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
November 30, 2016
Enrollment
1,902 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease (esrd)